News for HYACU Stock

Biote Debuts as Publicly Traded Company Focused on Transforming Hormone Optimization Industry Haymaker Acquisition Corp. III Announces Stockholder Approval of Business Combination with Biote Haymaker Acquisition Corporation III Reminds Shareholders to Vote in Favor of the Proposed Business Combination with Biote Before May 24 Biote Reports First Quarter 2022 Financial Results and Provides Corporate Update Biote Reports Record Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Outlook Biote Reports Record Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Outlook Biote to be Listed on Nasdaq through a Business Combination with Haymaker Acquisition Corp. III Haymaker Acquisition Corp. III Announces the Separate Trading of Its Class A Common Stock and Redeemable Warrants Commencing April 22, 2021 Haymaker Acquisition Corp. III Announces Closing of $300 Million Initial Public Offering Haymaker Acquisition Corp. III Announces Pricing of $300 Million Initial Public Offering ARKO / GPM Expands to Almost 3,000 Combined Company Operated and Wholesale Sites Across 33 States Haymaker, ARKO Holdings Ltd. and GPM Investments, LLC Announce Business Combination